AUPHHealthcareSmall-Cap
Aurinia Pharmaceuticals Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Aurinia Pharmaceuticals Inc. (AUPH), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are AUPH insiders buying or selling?
Aurinia Pharmaceuticals Inc. insiders reported 20 open-market buys ($63.2M) and 58 sells ($42.3M) across 78 Form 4 filings — a net buying position of $20.8M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jun 3, 2026)
Total Form 4 filings
78
SEC EDGAR
Insider filers
20
Insider buys (20)
$63.2M
Insider sells (58)
$42.3M
Insider sentiment
Net buyingNet insider flow of $20.8M in net buying. 1 insider buy in the last 90 days.
Recent AUPH insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 3, 2026 | Kevin Tang | Chief Executive Officer | Purchase | 814.6K | $15.29 | $12.5M |
| Mar 3, 2026 | Kevin Tang | Director | Purchase | 900.0K | $14.10 | $12.7M |
| Aug 5, 2025 | Kevin Tang | Director | Purchase | 1.3M | $10.45 | $13.6M |
| Aug 5, 2025 | Greg Keenan | Chief Medical Officer | Sale | 20.0K | $10.50 | $210.0K |
| Mar 7, 2025 | Greg Keenan | Chief Medical Officer | Sale | 8.3K | $8.23 | $68.4K |
| Mar 5, 2025 | Peter Greenleaf | Chief Executive Officer | Sale | 360.5K | $7.96 | $2.9M |
| Mar 5, 2025 | Greg Keenan | Chief Medical Officer | Sale | 12.2K | $8.00 | $97.9K |
| Mar 5, 2025 | Joseph M Miller | Chief Financial Officer | Sale | 118.0K | $7.96 | $939.6K |
| Mar 5, 2025 | Stephen P. Robertson | EVP, General Counsel | Sale | 122.5K | $7.96 | $975.2K |
| Mar 5, 2025 | Matthew Maxwell Donley | Chief Operating Officer | Sale | 124.9K | $7.96 | $994.4K |
| Mar 4, 2025 | Kevin Tang | Director | Purchase | 1.6M | $7.95 | $12.7M |
| Dec 9, 2024 | Kevin Tang | Director | Purchase | 1.2M | $9.02 | $10.8M |
| Nov 13, 2024 | Jeffrey Allen Bailey | Director | Sale | 4.6K | $8.43 | $38.4K |
| Nov 13, 2024 | Karen L. Smith | Director | Sale | 5.2K | $8.43 | $44.2K |
| Aug 8, 2024 | Scott Michael Habig | Chief Commercial Officer | Sale | 18.2K | $5.31 | $96.9K |
| May 22, 2024 | David R.W. Jayne | Director | Sale | 4.9K | $5.74 | $28.4K |
| Mar 7, 2024 | Peter Greenleaf | Chief Executive Officer | Sale | 127.0K | $5.60 | $711.1K |
| Mar 7, 2024 | Joseph M Miller | Chief Financial Officer | Sale | 34.8K | $5.60 | $194.9K |
| Mar 7, 2024 | Matthew Maxwell Donley | EVP, Ops & Strategy | Sale | 40.7K | $5.51 | $224.1K |
| Mar 7, 2024 | Scott Michael Habig | Chief Commercial Officer | Sale | 17.8K | $5.60 | $99.6K |
| Mar 7, 2024 | Stephen P. Robertson | EVP, General Counsel | Sale | 57.7K | $5.60 | $323.4K |
| Feb 29, 2024 | Volker Knappertz | EVP, Research and Development | Sale | 4.9K | $6.10 | $30.1K |
| Feb 22, 2024 | Volker Knappertz | EVP, Research and Development | Sale | 25.1K | $5.48 | $137.8K |
| Feb 22, 2024 | Scott Michael Habig | Chief Commercial Officer | Sale | 15.9K | $5.48 | $87.0K |
| Feb 22, 2024 | Stephen P. Robertson | EVP, General Counsel | Sale | 19.6K | $8.78 | $172.5K |
Showing the 25 most recent of 78 Form 4 filings for Aurinia Pharmaceuticals Inc..
Most active AUPH insiders
- Michael Robert Martin12 filings
- Neil Solomons7 filings
- Joseph M Miller6 filings
- Peter Greenleaf6 filings
- Kevin Tang5 filings
Ask anything about AUPH insider activity
Use Trabud's AI agent to query Aurinia Pharmaceuticals Inc.'s Form 4 history in plain English — "Show me AUPH CEO purchases this year" or compare it against any other ticker.
Open the AI agentAUPH insider trading FAQ
Are Aurinia Pharmaceuticals Inc. insiders buying or selling?
Across 78 SEC Form 4 filings, Aurinia Pharmaceuticals Inc. (AUPH) insiders reported 20 open-market purchases totaling $63.2M and 58 sales totaling $42.3M. That is a net buying position of $20.8M.
How many insiders trade AUPH stock?
20 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Aurinia Pharmaceuticals Inc.. The most recent filing was accepted on Jun 3, 2026.
Where does Trabud get AUPH insider trading data?
All AUPH insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.